269 results
Page 8 of 14
8-K
EX-99.1
lqziodby
27 Nov 12
Regulation FD Disclosure
12:00am
8-K
EX-99.1
skqm0umc 5qwwftvysq
20 Nov 12
LifeMap Sciences, a Subsidiary of BioTime, Signs Definitive Distribution Agreement with ProSpec-Tany TechnoGene
12:00am
8-K
EX-99.1
rxul4 k6x
19 Nov 12
LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.09
12:00am
8-K
EX-99.1
4m48wmqqo
15 Nov 12
BioTime Announces Non-Binding Letter of Intent with Geron Regarding Stem Cell Assets
12:00am
8-K
EX-99.2
q0j5xt
15 Nov 12
BioTime Announces Non-Binding Letter of Intent with Geron Regarding Stem Cell Assets
12:00am
8-K
EX-99.1
f0qt2xk
7 Nov 12
BioTime and Subsidiary Cell Cure Neurosciences Ltd. Announce Financing
12:00am
8-K
EX-99.1
bate6lt6mjvl
1 Nov 12
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
12:00am
8-K
EX-99.1
59c53i3
23 Oct 12
BioTime’s Subsidiary LifeMap Sciences, Inc. Announces the Launch of MalaCards - A Database of Human Diseases
12:00am
8-K
EX-99.1
mf3iufgh
19 Oct 12
LifeMap Sciences, Inc. Announces Addition to Board of Directors and Provides Update on Product Portfolio Development
12:00am
425
k4ayhv q9xvla282z
18 Oct 12
Business combination disclosure
12:00am
8-K
EX-99.1
iozxcw ej
28 Sep 12
BioTime Forms BioTime Acquisition Corporation
12:00am
8-K
EX-99.1
tlze okmvm
19 Sep 12
BioTime CEO Michael D. West to Present at Stem Cells USA & Regenerative Medicine Congress 2012
12:00am
8-K
EX-99.1
fgye 3t6z79
27 Aug 12
Other Events
12:00am
8-K
EX-99.1
uhpq9awfxe007mf178
16 Aug 12
BioTime and OncoCyte Corporation Publish Data on the Gene COL10A1 as a Marker and Potential Diagnostic for a Wide Array of Human Cancers
12:00am
8-K
EX-99.1
giz h2mn8ift
9 Aug 12
BioTime Announces Second Quarter 2012 Financial Results and Recent Corporate Accomplishments
12:00am
8-K
EX-99.1
mkju33e2 rribxly
1 Aug 12
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.33 Million Grant From Israel’s Office of the Chief Scientist
12:00am